Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Evaluation of a toxoid fusion protein vaccine produced in plants to protect poultry against necrotic enteritis.

Hunter JGL, Wilde S, Tafoya AM, Horsman J, Yousif M, Diamos AG, Roland KL, Mason HS.

PeerJ. 2019 Mar 28;7:e6600. doi: 10.7717/peerj.6600. eCollection 2019.

2.

Salmonella-vectored vaccine delivering three Clostridium perfringens antigens protects poultry against necrotic enteritis.

Wilde S, Jiang Y, Tafoya AM, Horsman J, Yousif M, Vazquez LA, Roland KL.

PLoS One. 2019 Feb 12;14(2):e0197721. doi: 10.1371/journal.pone.0197721. eCollection 2019.

3.

Bi-valent polysaccharides of Vi capsular and O9 O-antigen in attenuated Salmonella Typhimurium induce strong immune responses against these two antigens.

Li P, Liu Q, Luo H, Liang K, Han Y, Roland KL, Curtiss R 3rd, Kong Q.

NPJ Vaccines. 2018 Jan 9;3:1. doi: 10.1038/s41541-017-0041-5. eCollection 2018.

4.

Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated Salmonella enterica Serovar Typhimurium Vaccine Strains.

Łaniewski P, Baek CH, Roland KL, Curtiss R 3rd.

MBio. 2017 Aug 22;8(4). pii: e01189-17. doi: 10.1128/mBio.01189-17.

5.

Physiological fluid shear alters the virulence potential of invasive multidrug-resistant non-typhoidal Salmonella Typhimurium D23580.

Yang J, Barrila J, Roland KL, Ott CM, Nickerson CA.

NPJ Microgravity. 2016 Jun 9;2:16021. doi: 10.1038/npjmgrav.2016.21. eCollection 2016.

6.

Three-dimensional organotypic co-culture model of intestinal epithelial cells and macrophages to study Salmonella enterica colonization patterns.

Barrila J, Yang J, Crabbé A, Sarker SF, Liu Y, Ott CM, Nelman-Gonzalez MA, Clemett SJ, Nydam SD, Forsyth RJ, Davis RR, Crucian BE, Quiriarte H, Roland KL, Brenneman K, Sams C, Loscher C, Nickerson CA.

NPJ Microgravity. 2017 Feb 28;3:10. doi: 10.1038/s41526-017-0011-2. eCollection 2017.

7.

New Insights into the Roles of Long Polar Fimbriae and Stg Fimbriae in Salmonella Interactions with Enterocytes and M Cells.

Gonzales AM, Wilde S, Roland KL.

Infect Immun. 2017 Aug 18;85(9). pii: e00172-17. doi: 10.1128/IAI.00172-17. Print 2017 Sep.

8.

Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella Typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge.

Li P, Liu Q, Huang C, Zhao X, Roland KL, Kong Q.

Vaccine. 2017 May 15;35(21):2862-2869. doi: 10.1016/j.vaccine.2017.04.002. Epub 2017 Apr 12.

PMID:
28412074
9.

Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.

Liu Q, Liu Q, Yi J, Liang K, Liu T, Roland KL, Jiang Y, Kong Q.

Int J Med Microbiol. 2016 Dec;306(8):697-706. doi: 10.1016/j.ijmm.2016.08.004. Epub 2016 Aug 25.

10.

Protection Against Necrotic Enteritis in Broiler Chickens by Regulated Delayed Lysis Salmonella Vaccines.

Jiang Y, Mo H, Willingham C, Wang S, Park JY, Kong W, Roland KL, Curtiss R 3rd.

Avian Dis. 2015 Dec;59(4):475-85. doi: 10.1637/11094-041715-Reg.

PMID:
26629620
11.

A Live Oral Fowl Typhoid Vaccine with Reversible O-Antigen Production.

Mitra A, Łaniewski P, Curtiss R 3rd, Roland KL.

Avian Dis. 2015 Mar;59(1):52-6.

PMID:
26292534
12.

Characterization of the Invasive, Multidrug Resistant Non-typhoidal Salmonella Strain D23580 in a Murine Model of Infection.

Yang J, Barrila J, Roland KL, Kilbourne J, Ott CM, Forsyth RJ, Nickerson CA.

PLoS Negl Trop Dis. 2015 Jun 19;9(6):e0003839. doi: 10.1371/journal.pntd.0003839. eCollection 2015 Jun.

13.

Use of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.

Brenneman KE, Gonzales A, Roland KL, Curtiss R 3rd.

BMC Microbiol. 2015 Mar 29;15:76. doi: 10.1186/s12866-015-0409-5.

14.

Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public.

Dankel DJ, Roland KL, Fisher M, Brenneman K, Delgado A, Santander J, Baek CH, Clark-Curtiss J, Strand R, Curtiss R 3rd.

Nanoethics. 2014;8:179-185. Epub 2014 Jul 10.

15.

Evaluation of protective efficacy of live attenuated Salmonella enterica serovar Gallinarum vaccine strains against fowl typhoid in chickens.

Laniewski P, Mitra A, Karaca K, Khan A, Prasad R, Curtiss R 3rd, Roland KL.

Clin Vaccine Immunol. 2014 Sep;21(9):1267-76. doi: 10.1128/CVI.00310-14. Epub 2014 Jul 2.

16.

Membrane vesicles of Clostridium perfringens type A strains induce innate and adaptive immunity.

Jiang Y, Kong Q, Roland KL, Curtiss R 3rd.

Int J Med Microbiol. 2014 May;304(3-4):431-43. doi: 10.1016/j.ijmm.2014.02.006. Epub 2014 Feb 19.

17.

Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.

Jiang Y, Kong Q, Roland KL, Wolf A, Curtiss R 3rd.

Pathog Dis. 2014 Apr;70(3):390-400. doi: 10.1111/2049-632X.12153. Epub 2014 Mar 11.

18.

A low gastric pH mouse model to evaluate live attenuated bacterial vaccines.

Brenneman KE, Willingham C, Kilbourne JA, Curtiss R 3rd, Roland KL.

PLoS One. 2014 Jan 29;9(1):e87411. doi: 10.1371/journal.pone.0087411. eCollection 2014.

19.

Assessment of attenuated Salmonella vaccine strains in controlling experimental Salmonella Typhimurium infection in chickens.

Pei Y, Parreira VR, Roland KL, Curtiss R 3rd, Prescott JF.

Can J Vet Res. 2014 Jan;78(1):23-30.

20.

Salmonella as a vaccine delivery vehicle.

Roland KL, Brenneman KE.

Expert Rev Vaccines. 2013 Sep;12(9):1033-45. doi: 10.1586/14760584.2013.825454. Review. Erratum in: Expert Rev Vaccines. 2014 Mar;13(3):443.

21.

Low-pH rescue of acid-sensitive Salmonella enterica Serovar Typhi Strains by a Rhamnose-regulated arginine decarboxylase system.

Brenneman KE, Willingham C, Kong W, Curtiss R 3rd, Roland KL.

J Bacteriol. 2013 Jul;195(13):3062-72. doi: 10.1128/JB.00104-13. Epub 2013 May 3.

22.

Safety and protective efficacy of live attenuated Salmonella Gallinarum mutants in Rhode Island Red chickens.

Mitra A, Loh A, Gonzales A, Laniewski P, Willingham C, Curtiss Iii R, Roland KL.

Vaccine. 2013 Feb 4;31(7):1094-9. doi: 10.1016/j.vaccine.2012.12.021. Epub 2012 Dec 20.

PMID:
23261043
23.

Comparative genome analysis of the high pathogenicity Salmonella Typhimurium strain UK-1.

Luo Y, Kong Q, Yang J, Mitra A, Golden G, Wanda SY, Roland KL, Jensen RV, Ernst PB, Curtiss R 3rd.

PLoS One. 2012;7(7):e40645. doi: 10.1371/journal.pone.0040645. Epub 2012 Jul 6.

24.

The Campylobacter jejuni Dps homologue is important for in vitro biofilm formation and cecal colonization of poultry and may serve as a protective antigen for vaccination.

Theoret JR, Cooper KK, Zekarias B, Roland KL, Law BF, Curtiss R 3rd, Joens LA.

Clin Vaccine Immunol. 2012 Sep;19(9):1426-31. doi: 10.1128/CVI.00151-12. Epub 2012 Jul 11.

25.

Use of RapidChek® SELECT™ Salmonella to detect shedding of live attenuated Salmonella enterica serovar Typhi vaccine strains.

Brenneman KE, McDonald C, Kelly-Aehle SM, Roland KL, Curtiss R 3rd.

J Microbiol Methods. 2012 May;89(2):137-47. doi: 10.1016/j.mimet.2012.03.001. Epub 2012 Mar 8.

PMID:
22425882
26.

Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates.

Sizemore DR, Warner EA, Lawrence JA, Thomas LJ, Roland KL, Killeen KP.

Hum Vaccin Immunother. 2012 Mar;8(3):371-83. doi: 10.4161/hv.18670. Epub 2012 Feb 13.

PMID:
22327496
27.

Lrp acts as both a positive and negative regulator for type 1 fimbriae production in Salmonella enterica serovar Typhimurium.

Baek CH, Kang HY, Roland KL, Curtiss R 3rd.

PLoS One. 2011;6(10):e26896. doi: 10.1371/journal.pone.0026896. Epub 2011 Oct 28.

28.

Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant.

Kong Q, Six DA, Liu Q, Gu L, Roland KL, Raetz CR, Curtiss R 3rd.

Infect Immun. 2011 Dec;79(12):5027-38. doi: 10.1128/IAI.05524-11. Epub 2011 Sep 19. Erratum in: Infect Immun. 2012 Mar;80(3):1302.

29.

Developing live vaccines against plague.

Sun W, Roland KL, Curtiss R 3rd.

J Infect Dev Ctries. 2011 Sep 14;5(9):614-27. Review.

30.

Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.

Kong Q, Yang J, Liu Q, Alamuri P, Roland KL, Curtiss R 3rd.

Infect Immun. 2011 Oct;79(10):4227-39. doi: 10.1128/IAI.05398-11. Epub 2011 Jul 18.

31.

Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.

Kong Q, Six DA, Roland KL, Liu Q, Gu L, Reynolds CM, Wang X, Raetz CR, Curtiss R 3rd.

J Immunol. 2011 Jul 1;187(1):412-23. doi: 10.4049/jimmunol.1100339. Epub 2011 Jun 1. Erratum in: J Immunol. 2011 Sep 15;187(6):3449.

32.

A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.

Sun W, Six D, Kuang X, Roland KL, Raetz CR, Curtiss R 3rd.

Vaccine. 2011 Apr 5;29(16):2986-98. doi: 10.1016/j.vaccine.2011.01.099. Epub 2011 Feb 12. Erratum in: Vaccine. 2011 Aug 5;29(34):5820.

33.
34.

Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.

Wang S, Li Y, Shi H, Sun W, Roland KL, Curtiss R 3rd.

Infect Immun. 2011 Feb;79(2):937-49. doi: 10.1128/IAI.00445-10. Epub 2010 Dec 6.

35.
36.

Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.

Branger CG, Sun W, Torres-Escobar A, Perry R, Roland KL, Fetherston J, Curtiss R 3rd.

Vaccine. 2010 Dec 16;29(2):274-82. doi: 10.1016/j.vaccine.2010.10.033. Epub 2010 Oct 24.

37.

Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.

Wang S, Li Y, Scarpellini G, Kong W, Shi H, Baek CH, Gunn B, Wanda SY, Roland KL, Zhang X, Senechal-Willis P, Curtiss R 3rd.

Infect Immun. 2010 Sep;78(9):3969-80. doi: 10.1128/IAI.00444-10. Epub 2010 Jul 6.

38.

Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Shi H, Santander J, Brenneman KE, Wanda SY, Wang S, Senechal P, Sun W, Roland KL, Curtiss R.

PLoS One. 2010 Jun 18;5(6):e11142. doi: 10.1371/journal.pone.0011142.

39.

Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.

Wang S, Li Y, Shi H, Scarpellini G, Torres-Escobar A, Roland KL, Curtiss R 3rd.

Infect Immun. 2010 Jul;78(7):3258-71. doi: 10.1128/IAI.00176-10. Epub 2010 May 17.

40.

Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates.

Roland KL, Tinge SA, Kochi SK, Thomas LJ, Killeen KP.

Vaccine. 2010 May 7;28(21):3679-87. doi: 10.1016/j.vaccine.2010.03.019. Epub 2010 Mar 23.

PMID:
20338215
41.

Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Sun W, Roland KL, Kuang X, Branger CG, Curtiss R 3rd.

Infect Immun. 2010 Mar;78(3):1304-13. doi: 10.1128/IAI.01122-09. Epub 2010 Jan 19.

42.

Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers.

Shi H, Wang S, Roland KL, Gunn BM, Curtiss R 3rd.

Clin Vaccine Immunol. 2010 Mar;17(3):363-71. doi: 10.1128/CVI.00413-09. Epub 2010 Jan 6.

43.
44.

The role of relA and spoT in Yersinia pestis KIM5 pathogenicity.

Sun W, Roland KL, Branger CG, Kuang X, Curtiss R 3rd.

PLoS One. 2009 Aug 24;4(8):e6720. doi: 10.1371/journal.pone.0006720.

45.

PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.

Xin W, Li Y, Mo H, Roland KL, Curtiss R 3rd.

Infect Immun. 2009 Oct;77(10):4518-28. doi: 10.1128/IAI.00486-09. Epub 2009 Aug 17.

46.

Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica.

Branger CG, Torres-Escobar A, Sun W, Perry R, Fetherston J, Roland KL, Curtiss R 3rd.

Vaccine. 2009 Aug 27;27(39):5363-70. doi: 10.1016/j.vaccine.2009.06.078. Epub 2009 Jul 9.

47.

Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.

Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda SY, Roland KL, Curtiss R 3rd.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):593-8. doi: 10.1073/pnas.0811697106. Epub 2008 Dec 29.

48.

Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium.

Baek CH, Wang S, Roland KL, Curtiss R 3rd.

J Bacteriol. 2009 Feb;191(4):1278-92. doi: 10.1128/JB.01142-08. Epub 2008 Dec 12.

49.

A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.

Li Y, Wang S, Xin W, Scarpellini G, Shi Z, Gunn B, Roland KL, Curtiss R 3rd.

Infect Immun. 2008 Nov;76(11):5238-46. doi: 10.1128/IAI.00720-08. Epub 2008 Sep 2.

50.

Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment.

Kong W, Wanda SY, Zhang X, Bollen W, Tinge SA, Roland KL, Curtiss R 3rd.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9361-6. doi: 10.1073/pnas.0803801105. Epub 2008 Jul 7.

Supplemental Content

Loading ...
Support Center